| GSK PLC SP. ADR/2 NEW |
| USA |
| Gesundheit |
| US37733W2044 / A3DMHS |
| GS70 (Frankfurt) / GSK (NYSE) |
| FRA:GS70, ETR:GS70, GS70:GR, NYSE:GSK |
| - |
| https://www.gsk.com/ |
|
GSK plc Sponsored ADR represents shares in GSK plc, a global healthcare company headquartered in Middlesex, United Kingdom, and founded in 1715. The company focuses on the research, development, and manufacture of pharmaceutical medicines, vaccines, ..
>Volltext.. |
| 90022.23 Mio. EUR |
| 107629.41 Mio. EUR |
| 38630.62 Mio. EUR |
| 13196.44 Mio. EUR |
| 6883.46 Mio. EUR |
| 3.41 EUR |
| 22098.55 Mio. EUR |
| 3991.56 Mio. EUR |
| 8550.14 Mio. EUR |
| 0.15 |
| 9.19% |
| 96.65% |
| 1.54 EUR |
| 3.44% |
| 3.44% |
| 15.05.26 - 0.39606258€ 20.02.26 - 0.412035€ >weitere anzeigen... |
| - |
| GSK ADR, GSK, GLAXOSMITHKLINE, GLAXO |
| 28.07.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|